234 Importance of timing for thoracic irradiation (TI) in the combined modality treatment of limited-stage small-cell lung cancer (LSCLC): An update of the National Cancer Institute of Canada (NCIC) BR6 study

Murray, Nevin; Zee, B.; Pater, Joseph L.; Coy, Peter; Hodson, I.; Arnold, Alesha; Payne, Debbie; Kostashuk, E.; Wk, Evans; Dixon, Pam; Sadura, Anna; Feld, R.; Levitt, Mark L.; Wierzbicki, Ryszard; Ayoub, Jean-Pierre; Maroun, J.; Wilson, Kevin

doi:10.1016/s0169-5002(97)89616-x

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2002

2016

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The survey shows that most practitioners follow evidence‐based practice where evidence exists. This may be affected by resource or patient factors for example in SCLC, where many chose 40 Gy/15# once daily as per Murray et al rather than a b.d. regimen and in node negative locally advanced NSCLC where many use hypofractionation.…”

Section: Discussionmentioning

confidence: 99%

Lung cancer radiation therapy in Australia and New Zealand: Patterns of practice

et al. 2016

View full text Add to dashboard Cite

A significant proportion of ROs did not have access to 4D-CT. The majority used 3D image verification and consistently prescribed evidence based doses. A significant number did not participate in peer-review of contours. Practice in IMRT and synchronous oligo-metastatic disease is variable and should be an area of future research. Utilising survey findings, FROLIC is developing consensus recommendations to guide practice.

show abstract

Section: Discussionmentioning

confidence: 99%